2Spertus JA, Kettelkamp R, Vance C, et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug - eluting stent placement:results from the PREMIER reg- istry [ J 1. Circulation, 2006,113 ( 24 ) :2803 - 2809.
3Marjo HT,Mattie L, William W, et al. Patients enrolled in coronary intervention trials are not representative of patients in clinical prac- tice: resnlts from the Euro Heart Survey on Coronary Revasculariza-tion[J]. Eur Heart J,2006,27:671 -678.
4陈珠.实用内科[M].北京:人民卫生出版社,2005:1386.
5Moficem C, Serruysp W, Sousa JE, et al. A randomized comparison of a sirolinus eluting stentwith a standard stent for coronary revascu~ larization [ J ]. N Engl J Med ,2002 ,346 (23) : 1773 - 1780.
6Schampaert E,Cohen EA,Schluter M,et al. The canadian study of the sirolinus-eluting stent in the treatment of patientswith long de novo lesions in small native coronary arteries( C - SIRIUS) [ J]. J Am Coll Cordiol,20og,g3 (6) :1110 -1115.
